How should we count AgNORS? Proposals for a standardized approach

J Crocker, D.A.R. Boldy, Mark Egan

The Journal of Pathology

Standardized ApproachFixation MethodsMedicineHistopathologyIntranucleolar Agnor Dots +13

Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers

J. Arklie, Joyce Taylor‐Papadimitriou, Walter F. Bodmer, +2

International Journal of Cancer

Differentiation AntigensBreast OncologyImmunologyPathologyAntibody 3.14.A3 +16

Nucleolar organizer regions in cutaneous tumours

Mark Egan, J Crocker

The Journal of Pathology

Correlation between nor sizes and numbers in non‐Hodgkin's lymphomas

J Crocker, Mark Egan

The Journal of Pathology

Lymphoid NeoplasiaOncologyEngineeringMedical ImagingMedicine +13

Nucleolar organiser regions in fibrous proliferations of childhood and infantile fibrosarcoma.

Mark Egan, F. Raafat, J Crocker, +1

Journal of Clinical Pathology

FibrosisDevelopmental BiologyInfantile FibrosarcomaSilver Colloid TechniqueEar Molding +12

Nucleolar organizer regions in small cell tumours of childhood

Mark Egan, F. Raafat, J Crocker, +1

The Journal of Pathology

Silver Colloid TechniqueHealth SciencesTumor HeterogeneityMedicineHistopathology +11

Fork-tip needle biopsy versus fine-needle aspiration in endoscopic ultrasound-guided sampling of solid pancreatic masses: a randomized crossover study

Kofi Oppong, Noor Bekkali, John Leeds, +6

Endoscopy

Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancers

P J Hainsworth, Mark Egan, W.J. Cunliffe

British journal of surgery

Surgical OncologyColorectal SurgeryAnterior ResectionRectosigmoid CancersMedicine +10

Comparative study of the degree of differentiation of neuroblastoma and mean numbers of nucleolar organiser regions.

Mark Egan, F. Raafat, J Crocker, +1

Journal of Clinical Pathology

Pediatric Brain TumorsChildhood NeuroblastomaPathologyAnatomyNucleolar Organiser Regions +17

Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.

Mark Egan, Joseph T. Newman, J Crocker, +1

PubMed

S100 ProteinFibrosisBreast OncologyImmunohistochemical LocalizationMalignant Disease +12